2016 NY meeting

1st INTERNATIONAL KELOID SYMPOSIUM at THE ROCKEFELLER UNIVERSITY

New York, NY – September 8-9, 2016

Time
Speaker
Title

DAY 1
Thursday, September 8th 2016

Welcome & Introduction
8:45 - 9:00
(8:45 AM-9:00 AM)
James G. Krueger, MD PhD
Michael H. Tirgan, MD &
Ardeshir Bayat, MBBS PhD
Welcome to The Rockefeller University & Opening of the 1st International Keloid Symposium
KEYNOTE
9:00-9:30
(9:00 AM-9:30 AM)
Geoff Gurtner, MD PhD
Stanford University,
California, USA
Mechanotransduction and Raised Skin Scarring
9:30-9:50
(9:30 AM-9:50 AM)
Daniel Siegel, MD
SUNY Downstate Medical Center,
New York, USA
Compensation for Keloid Management in the USA: What, why and how it could be improved
9:50-10:10
(9:50 AM-10:10 AM)
Frank Niessen, MD PhD
University of Amsterdam, Amsterdam, Holland
What We Can Learn from Recurrent Keloid Formation
KEYNOTE
10:10-10:40
(10:10 AM-10:40 AM)
Edward Tredget, MD MSC FRCS(C)
University of Alberta, Edmonton, Canada
Hypertrophic Scars

COFFEE

10:40-11.10
(10:40 AM-11.10 AM)

COFFEE BREAK

KEYNOTE
11:10-11:40
(11:10 AM-11:40 AM)
Thomas Mustoe, MD FACS
University of Illinois,
Illinois, USA
New Insights into the Treatment of Hypertrophic Scars
11:40-12:00
(11:40 AM-12:00 PM)
Patricia Danielsen, MD PhD
University of Denmark
Copenhagen, Denmark
Clinical Keloid Scar Disease Trials - Design, Methods and Meaningful Outcomes
12:00-12:20
(12:00 PM-12:20 PM)
Ardeshir Bayat, MBBS, PhD
University of Manchester
Manchester, UK
Keloid scar versus disease: quasi-neoplastic tendencies of cutaneous healing in susceptible individuals
KEYNOTE
12:20-12:50
(12:20 PM-12:50 PM)
Guyan DL Arscott, MD
University of West Indies Kingston, Jamaica
Management of Keloids: Lessons from Jamaica

LUNCH

12:50-13:50
(12:50 PM-1:50 PM)

LUNCH – CRC Cafeteria – Weiss Café

KEYNOTE
13:50-14:20
(1:50 PM-2:20 PM)
Brian Berman, MD PhD
University of Miami,
Florida, USA
Controlling Excessive Scarring and Keloids
14:20-14:40
(2:20 PM-2:40 PM)
Donald Glass, MD PhD
University of Texas Southwestern,
Texas, USA
Overview of the Genetics of Keloid Scars
14:40-15:00
(2:40 PM-3:00 PM)
Jared Jagdeo, MD MS
University California - Davis, California, USA
Pioneering High Fluence Light Emitting Diode-red Light for Keloid Scars: Preclinical and Phase I Clinical Trial Safety Data
15:00-15:20
(3:00 PM-3:20 PM)
Jeremy Brauer, MD
NYU Langone Medical Center,
New York, USA
Use of Lasers in Managing Keloids

COFFEE

15:20- 15:50
(3:20 PM- 3:50 PM)

COFFEE BREAK

15:50- 16:10
(3:50 PM-4:10 PM)
Chandan Sen, PhD
Ohio State University,
Ohio, USA
Non-invasive Non-viral Topical Direct Skin Cell Reprogramming In Vivo
KEYNOTE
16:10-16:40
(4:10 PM-4:40 PM)
Phan Toan Thang, MD PhD
University of Singapore, Singapore
Epidermal Biosignalling as a Novel Target for Keloid Therapy
Interactive Clinical Case Presentations
16:40- 17:30
(4:40 PM-5:30 PM)
Organizing Committee/Invited faculty will deliver educational case presentations
17:30
(5:30 PM)
James G. Krueger, MD PhD
Michael H. Tirgan, MD &
Ardeshir Bayat, MBBS PhD
Closing Remarks for Day One

RECEPTION

17:30-18:30
(5:30 PM-6:30 PM)

ABBY LOUNGE

Time
Speaker
Title

DAY 2
Friday, September 9th 2016

REGISTRATION START
7:45-8:45
(7:45 AM-8:45 AM)
Registration & Set-up of posters,
SPEAKER TALK UPLOAD

BREAKFAST

7:45-8:45
(7:45 AM-8:45 AM)

CRC CAFETERIA

Welcome & Introduction
8:45-9:00
(8:45 AM-9:00 AM)
James G. Krueger, MD PhD
Michael H. Tirgan, MD &
Ardeshir Bayat, MBBS PhD
Welcome and Introduction to Day 2 of 1st International Keloid Symposium
Plenary
9:00-9:40
(9:00 AM-9:40 AM)
Michael Longaker, MD MBA FACS
Stanford University,
California, USA
Identifying a Lineage of Fibroblasts that are a Cellular Culprit for Scarring
9:40-10:00
(9:40 AM-10:00 AM)
Tai-Lan Tuan, PhD
University of Southern
California, USA
Keloid-derived, Plasma/Fibrin-Based Skin Equivalents Generate De Novo Dermal and Epidermal Pathology of Keloid Fibrosis in a Mouse Model
10:00-10:20
(10:00 AM-10:20 AM)
Dorothy Supp, PhD
University of Cincinnati,
Ohio, USA
EMT in Keloids
KEYNOTE
10:20-10:50
(10:20 AM-10:50 AM)
Aziz Ghahary, MSc PhD
University of British Columbia,
Vancouver, Canada
A New Strategy in Preventing Hypertrophic and Keloid Scars

COFFEE

10:50-11:20
(10:50 AM-11:20 AM)

COFFEE BREAK

KEYNOTE
11:20-11:50
(11:20 AM-11:50 AM)
Shirley Russell, PhD
Vanderbilt University,
Tennessee, USA
Keloids: An In-vitro Model of Fibroproliferative Disease
11:50-12:10
(11:50 AM -12:10 PM)
James G. Krueger MD PhD
Rockefeller University
New York, USA
Molecular profiling of keloids in African-American Patients
12:10-12:30
(12:10 PM-12:30 PM)
Christine Theoret, DVM PhD
University of Montreal,
Canada
Regeneration in Other Species: Keloid-like Pathology in Horses
12:30:12:50
(12:30 PM-12:50 PM)
Susan Volk, VMD PhD
University of Pennsylvania,
Pennsylvania, USA
Collagen in the Wound Healing Fibrosis-cancer Triad: Lessons from Animal Models

LUNCH

12:50-13:50
(12:50 PM-1:50 PM)

LUNCH – CRC Cafeteria – Weiss Café

KEYNOTE
13:50-14:20
(1:50 PM-2:20 PM)
George Yang, MD PhD
Stanford University,
California, USA
Targeting Stress Responses for Therapy of Keloids
14:20-14:40
(2:20 PM-2:40 PM
Lamont Jones, MD MBA
Henry Ford Health System,
Michigan, USA
Head & Neck Keloids: Epidemiology and Epigenetic Signatures
14:40-15:10
(2:40 PM-3:10 PM)
Jeanette Wilburn, MSc
Galen Research,
Manchester, UK
Establishing Patient Value in Keloid Intervention

COFFEE

15:10- 15:40
(3:10 PM- 3:40 PM)

COFFEE BREAK

15:40-16:00
(3:40 PM-4:00 PM)
Sundeep Keswani, MD
Texas Children’s Hospital
Texas, USA
Regeneration in Human Foetuses
16:00-16:20
(4:00 PM-4:20 PM)
Michael H. Tirgan, MD
New York, USA
Medical Management of Keloid Disorder
POSTER TALKS
16:20-17:15
(4:20 PM-4:45 PM)
Short oral submitted abstract presentations &
Organizing Committee/Invited faculty will deliver educational case presentations
Closing Ceremony & Closing Remarks
17:15- 17:30
(5:15 PM-5:30 PM)
James G. Krueger, MD PhD
Michael H. Tirgan, MD &
Ardeshir Bayat, MBBS PhD
CLOSING REMARKS

THANK YOU FOR YOUR PARTICIPATION
PLEASE REMEMBER TO TURN IN YOUR EVALUATIONS

Clinical Directors Network (CDN) is an approved provider of CME through the American Academy of Family Physicians. This activity is pending for up to 13 prescribed credits by the American Academy of Family Physicians.

cdn